Loading...
•
Jun 30, 2023
Danaher Q2 2023 Earnings Report
Danaher's second quarter results met expectations, with better-than-expected performance in Life Science and Diagnostics businesses offsetting softer demand in bioprocessing.
Key Takeaways
Danaher reported Q2 2023 results with revenues decreasing 7.5% year-over-year to $7.2 billion. Net earnings were $1.1 billion, or $1.49 per diluted common share, while non-GAAP adjusted diluted net earnings per common share were $2.05. The company anticipates non-GAAP base business core revenue will be down low-single digits year-over-year for Q3 2023 and up low-single digits year-over-year for full year 2023.
Revenues decreased 7.5% year-over-year to $7.2 billion.
Net earnings were $1.1 billion, or $1.49 per diluted common share.
Non-GAAP adjusted diluted net earnings per common share were $2.05.
Operating cash flow was $1.9 billion and non-GAAP free cash flow was $1.6 billion.
Forward Guidance
For the third quarter 2023, the Company anticipates that non-GAAP base business core revenue will be down low-single digits year-over-year. For full year 2023, the Company anticipates that non-GAAP base business core revenue growth will be up low-single digits year-over-year.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...